Loading clinical trials...
Loading clinical trials...
A Six-month, Prospective, Multicenter, Open Label, Parallel, Randomized Study of the Safety, Tolerability and Efficacy of EC-MPS With Basiliximab, Corticosteroids and Two Different Levels of Tacrolimus in de Novo Renal Transplant Recipients
Conditions
Interventions
EC-MPS, Tacrolimus
Locations
1
United States
Novartis
East Hanover, New Jersey, United States
Start Date
September 1, 2005
Primary Completion Date
March 1, 2007
Completion Date
March 1, 2007
Last Updated
February 7, 2017
NCT07415421
NCT06958796
NCT07294547
NCT07224763
NCT06972069
NCT05234463
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions